Alexandros Spyridonidis

Institute of Cell Therapy, University of Patras

Research Area

Biography

Alexandros Spyridonidis has not added Biography.
If you are Alexandros Spyridonidis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2023

Other Publications

Article	Year
DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation. Chimerism\| PubMed ID: 21547035	2011
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Worki... Leukemia\| PubMed ID: 22290066	2012
DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation. International journal of molecular sciences\| PubMed ID: 23443095	2012
Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice. Biochimica et biophysica acta\| PubMed ID: 26170061	2015
The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells. Scientific reports\| PubMed ID: 28106085	2017
Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host di... Cytotherapy\| PubMed ID: 28162915	2017
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell stem cell\| PubMed ID: 28215825	2017
How much immunosuppression do we need? Blood\| PubMed ID: 28280046	2017
Plasma and Serum Metabolite Association Networks: Comparability within and between Studies Using NMR and MS Profiling. Journal of proteome research\| PubMed ID: 28517934	2017
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine\| PubMed ID: 29431743	2018
Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling. Blood advances\| PubMed ID: 29669754	2018
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone marrow transplantation\| PubMed ID: 31996792	2020
Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switz... Leukemia research\| PubMed ID: 32135394	2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone marrow transplantation\| PubMed ID: 32144364	2020
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with -internal tandem duplication: a position statement from the Acute Leukemi... Haematologica\| PubMed ID: 32241850	2020
Remdesivir and tocilizumab: Mix or match. Journal of medical virology\| PubMed ID: 32492200	2021
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study. Microorganisms\| PubMed ID: 33260775	2020
"Cerberus" T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients. Frontiers in immunology\| PubMed ID: 33537032	2020
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays. Scientific reports\| PubMed ID: 33758278	2021
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone marrow transplantation\| PubMed ID: 35501565	2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Transplantation and cellular therapy\| PubMed ID: 36031079	2022
Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on be... Bone marrow transplantation\| PubMed ID: 36071114	2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone marrow transplantation\| PubMed ID: 36207624	2022
To Transplant or Not To Transplant in First Remission Acute Lymphoblastic Leukemia? Study group data give some answers, but not all. Transplantation and cellular therapy\| PubMed ID: 36470611	2022
Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients? British journal of haematology\| PubMed ID: 36477621	2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party... HemaSphere\| PubMed ID: 36698616	2023
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission. British journal of haematology\| PubMed ID: 36949658	2023
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming. Cancers\| PubMed ID: 37046597	2023
Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens! Blood transfusion = Trasfusione del sangue\| PubMed ID: 37146299	2023
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working ... Bone marrow transplantation\| PubMed ID: 37147469	2023
Study protocol: Phase I/II trial of induced HLA-G regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor. Frontiers in medicine\| PubMed ID: 37275377	2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood... Bone marrow transplantation\| PubMed ID: 37386253	2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remissio... HemaSphere\| PubMed ID: 37746158	2023